Literature DB >> 8350420

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

G J Cox1, T J Zamb, L A Babiuk.   

Abstract

Mice and cattle injected with plasmids encoding bovine herpesvirus 1 (BHV-1) glycoproteins developed gene-specific antibody responses capable of neutralizing BHV-1. The ability of animals to respond serologically to DNA injections was in part dependent on the quantity of DNA injected and was also negatively affected by carrier DNA. Calves injected with a plasmid encoding BHV-1 gIV developed significant antibody titers to gIV and shed less virus than did the control calf after challenge. This report indicates the potential of DNA injection as a method of vaccination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350420      PMCID: PMC237973     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Conditions affecting direct gene transfer into rodent muscle in vivo.

Authors:  J A Wolff; P Williams; G Acsadi; S Jiao; A Jani; W Chong
Journal:  Biotechniques       Date:  1991-10       Impact factor: 1.993

2.  Different functions of subsets of effector T cells in murine influenza virus infection.

Authors:  K N Leung; G L Ada
Journal:  Cell Immunol       Date:  1982-03-01       Impact factor: 4.868

3.  Expression of recombinant genes in myocardium in vivo after direct injection of DNA.

Authors:  H Lin; M S Parmacek; G Morle; S Bolling; J M Leiden
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

4.  Direct gene transfer into mouse muscle in vivo.

Authors:  J A Wolff; R W Malone; P Williams; W Chong; G Acsadi; A Jani; P L Felgner
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

Review 5.  A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.

Authors:  W D Yates
Journal:  Can J Comp Med       Date:  1982-07

6.  Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs.

Authors:  G Acsadi; G Dickson; D R Love; A Jani; F S Walsh; A Gurusinghe; J A Wolff; K E Davies
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

7.  Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; B Massie; J V van den Hurk; R Harland; L A Babiuk; T J Zamb
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

8.  Strong expression of foreign genes following direct injection into fish muscle.

Authors:  E Hansen; K Fernandes; G Goldspink; P Butterworth; P K Umeda; K C Chang
Journal:  FEBS Lett       Date:  1991-09-23       Impact factor: 4.124

9.  Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers.

Authors:  K T McKee; W H Bancroft; K H Eckels; R R Redfield; P L Summers; P K Russell
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves.

Authors:  R J Harland; A A Potter; S van Drunen-Littel-van den Hurk; J Van Donkersgoed; M D Parker; T J Zamb; E D Janzen
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

View more
  57 in total

1.  DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.

Authors:  Lian-San Zhao; Shan Qin; Tao-You Zhou; Hong Tang; Li Liu; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

Authors:  S Zucchelli; S Capone; E Fattori; A Folgori; A Di Marco; D Casimiro; A J Simon; R Laufer; N La Monica; R Cortese; A Nicosia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

5.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Virus-specific cytotoxic T-lymphocyte activity elicited by coimmunization with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein.

Authors:  M J Selby; B Doe; C M Walker
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

Authors:  J B Ulmer; T M Fu; R R Deck; A Friedman; L Guan; C DeWitt; X Liu; S Wang; M A Liu; J J Donnelly; M J Caulfield
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

9.  Evolving importance of biologics and novel delivery systems in the face of microbial resistance.

Authors:  Terry L Bowersock
Journal:  AAPS PharmSci       Date:  2002

10.  Simian immunodeficiency virus DNA vaccine trial in macaques.

Authors:  S Lu; J Arthos; D C Montefiori; Y Yasutomi; K Manson; F Mustafa; E Johnson; J C Santoro; J Wissink; J I Mullins; J R Haynes; N L Letvin; M Wyand; H L Robinson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.